Doxorubicin Hydrochloride Liposome Injection
Northstar Rx is recalling Doxorubicin Hydrochloride Liposome injection 50 mg/25 mL vials due to potential glass particulate contamination.
Contact your healthcare provider or pharmacist if you have concerns about this medication. Do not use the affected product.
Why it was recalled
Northstar Rx is recalling Doxorubicin Hydrochloride Liposome injection due to the presence of particulate matter identified as glass. This recall affects 50 mg/25 mL single-dose vials.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
DOXOrubin Hydrochloride Liposome injection
- Strength
- 50 mg
- NDC / UPC
- NDC 72603-200-01
Official source
Other recent recalls from SUN PHARMACEUTICAL INDUSTRIES INC
Editorial summary by Recall Canary · last updated 2026-06-06 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification